Munafa Stock Market Course + Intraday & FNO calls 
Glaxosmithkline Plc (GSK) Technical (Analysis) Reports Glaxosmithkline Plc ["Technical Analysis"] Reports -NYSE Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Glaxosmithkline Plc (GSK)
Technical Analysis Report for NYSE stock GSK Glaxosmithkline Plc. Dated: 01 May 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NYSE stock exchange
If you are looking for Tomorrow's Movement Predictions for NYSE stock GSK Glaxosmithkline Plc then click here. or read Experts views on Glaxosmithkline Plc or Forecast & share price targets of Glaxosmithkline Plc
Glaxosmithkline Plc Opened at 51.80 and Closed at: 51.61, which is -1.36% of previous session's close. It moved within a range of 51.52 and 52.23
The session was a Bearish session with an average volume of 3938100, which is -30.73% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
A Dead cross was found 5 days back on short term averages
A Dead cross was found 4 days back on mid term averages
Support for tomorrow is 51.21 and resistance for tomorrow is 51.92
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 51.34, 51.08 resistance for tomorrow's hourly charts is 52.05, 52.5
10 Day SMA for Glaxosmithkline Plc (GSK) is 54.33 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Glaxosmithkline Plc (GSK) is 56.04 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Glaxosmithkline Plc (GSK) is 55.86 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 53.74 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Glaxosmithkline Plc is 47.97 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Glaxosmithkline Plc is at 56.04 and 200 DMA is at 47.97, while 50 DMA and 100 DMA are at 55.86 and 53.74 respectively
Glaxosmithkline Plc (GSK) moving average of 20 SMA is at 56.04 and 20 EMA is at 54.9
| Date | Closing Price | 20 SMA | 20 EMA |
| 01 Fri May | 51.61 | 56.04 | 54.9 |
| 30 Thu Apr | 52.31 | 56.3 | 55.25 |
| 29 Wed Apr | 51.40 | 56.48 | 55.56 |
| 28 Tue Apr | 54.47 | 56.67 | 56 |
| 27 Mon Apr | 54.22 | 56.66 | 56.16 |
| 24 Fri Apr | 54.44 | 56.64 | 56.36 |
Glaxosmithkline Plc (GSK) moving average of 50 SMA is at 55.86 and 50 EMA is at 55.07
| Date | Closing Price | 50 SMA | 50 EMA |
| 01 Fri May | 51.61 | 55.86 | 55.07 |
| 30 Thu Apr | 52.31 | 56.05 | 55.21 |
| 29 Wed Apr | 51.40 | 56.22 | 55.33 |
| 28 Tue Apr | 54.47 | 56.37 | 55.49 |
| 27 Mon Apr | 54.22 | 56.46 | 55.53 |
| 24 Fri Apr | 54.44 | 56.55 | 55.58 |
Glaxosmithkline Plc (GSK) moving average of 100 SMA is at 53.74 and 100 EMA is at 53.31
| Date | Closing Price | 100 SMA | 100 EMA |
| 01 Fri May | 51.61 | 53.74 | 53.31 |
| 30 Thu Apr | 52.31 | 53.71 | 53.34 |
| 29 Wed Apr | 51.40 | 53.67 | 53.36 |
| 28 Tue Apr | 54.47 | 53.65 | 53.4 |
| 27 Mon Apr | 54.22 | 53.59 | 53.38 |
| 24 Fri Apr | 54.44 | 53.52 | 53.36 |
Glaxosmithkline Plc (GSK) moving average of 200 SMA is at 47.97 and 200 EMA is at 49.46
| Date | Closing Price | 200 SMA | 200 EMA |
| 01 Fri May | 51.61 | 47.97 | 49.46 |
| 30 Thu Apr | 52.31 | 47.91 | 49.44 |
| 29 Wed Apr | 51.40 | 47.84 | 49.41 |
| 28 Tue Apr | 54.47 | 47.78 | 49.39 |
| 27 Mon Apr | 54.22 | 47.7 | 49.34 |
| 24 Fri Apr | 54.44 | 47.62 | 49.29 |
Glaxosmithkline Plc has performed better than Zimmer Biomet in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Unitedhealth Group has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Unitedhealth Group, about 39.51% more returns!
Universal Health has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Universal Health, about 0.56% more returns!
Tenet Healthcare has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Tenet Healthcare, about 4.78% more returns!
Glaxosmithkline Plc has performed better than Stryker Corporation in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Select Medical has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Select Medical, about 8.83% more returns!
Glaxosmithkline Plc has performed better than Resmed Inc in short term. Holding Glaxosmithkline Plc could be a better choice for now!
Abbvie Inc has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Abbvie Inc, about 8.42% more returns!
Baxter International has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Baxter International, about 11.82% more returns!
Becton Dickinson has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Becton Dickinson, about 4.59% more returns!
Fresenius Medical has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Fresenius Medical, about 8.5% more returns!
Globus Medical has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Globus Medical, about 11.55% more returns!
Humana Inc has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Humana Inc, about 36.32% more returns!
Johnson Johnson has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Johnson Johnson, about 2.78% more returns!
Laboratory Corporation has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Laboratory Corporation, about 1.68% more returns!
Eli Lilly has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Eli Lilly, about 12.42% more returns!
Medtronic Plc has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Medtronic Plc, about 1.18% more returns!
Arcus Biosciences has performed better than Glaxosmithkline Plc in short term. You could have earned much better returns by investing in Arcus Biosciences, about 23.93% more returns!
Glaxosmithkline Plc Technical analysis of indicators
Price action analysis of Glaxosmithkline Plc (GSK) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Glaxosmithkline Plc stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Glaxosmithkline Plc in short term and the sell signal is strong.
Glaxosmithkline Plc Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Glaxosmithkline Plc in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Glaxosmithkline Plc is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 53.82 and Glaxosmithkline Plc GSK stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Glaxosmithkline Plc GSK stock. Volume based technical analysis of Glaxosmithkline Plc GSK stock is negative.
Glaxosmithkline Plc Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NYSE stock GSK Glaxosmithkline Plc These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And GSK Experts View which covers a lot of information including buying and selling signals
GSK future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Glaxosmithkline Plc or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Glaxosmithkline Plc (GSK) Technical (Analysis) Reports Glaxosmithkline Plc ["Technical Analysis"] Reports -NYSE Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- NYSE Screeners
- NYSE Daily Screener
- NYSE Weekly Screener
- NYSE Monthly Screener
- Support & Resistance
- NYSE Shares Near Support
- NYSE Shares Near Resistance
